Femasys (FEMY) to Release Earnings on Thursday

Femasys (NASDAQ:FEMY) is expected to issue its quarterly earnings data before the market opens on Thursday, March 27th. Analysts expect the company to announce earnings of ($0.25) per share for the quarter.

Femasys Trading Up 1.9 %

NASDAQ:FEMY opened at $1.57 on Thursday. The stock has a fifty day moving average price of $1.35 and a two-hundred day moving average price of $1.21. The stock has a market capitalization of $35.95 million, a price-to-earnings ratio of -1.94 and a beta of -2.85. The company has a debt-to-equity ratio of 0.86, a quick ratio of 3.26 and a current ratio of 3.94. Femasys has a 1 year low of $0.86 and a 1 year high of $1.88.

Wall Street Analyst Weigh In

Separately, HC Wainwright raised their price target on Femasys from $12.00 to $15.00 and gave the company a “buy” rating in a research report on Wednesday.

Femasys Company Profile

Femasys Inc, a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs worldwide. The company provides FemVue saline-air device, a contrast-generating product in the United States, Canada, Japan, and Hong Kong; FemCath, a cornual balloon catheter, a single intrauterine directional delivery product that allows for selective evaluation of an individual fallopian tube; and FemCerv, a biopsy device for endocervical curettage, which can be used to sample cervical cells and tissue circumferentially with sample containment within the device to minimize contamination.